WednesdayFeb 18, 2026 11:14 am

QualityStocksNewsBreaks – SEGG Media Corporation (NASDAQ: SEGG, LTRYW) Nominates Veloce CEO Daniel Bailey to Board of Directors 

SEGG Media (NASDAQ: SEGG, LTRYW) announced the nomination of Daniel Bailey, Co-Founder and Chief Executive Officer of Veloce Media Group, to its Board of Directors in connection with the Company’s acquisition of Veloce. SEGG Media said Bailey’s appointment enhances board-level expertise in digital audience monetization, brand partnerships, international expansion and scalable media execution as it advances its 2026 growth strategy. Under Bailey’s leadership, Veloce expanded across esports, motorsport and digital content, building partnerships with global brands including McLaren, Visa, Microsoft, Hilton and LEGO, and recently structured the acquisition of Quadrant, a motorsport content business co-founded by 2025 Formula One World Champion Lando Norris. To view the full…

Continue Reading

WednesdayFeb 18, 2026 11:10 am

QualityStocksNewsBreaks – New Silver Income Fund Ranks No. 4 in BarclayHedge 2025 Fixed Income Asset-Backed Loans Category

New Silver, a technology-driven private lender focused on residential real estate investment financing, announced that its New Silver Income Fund ranked No. 4 in BarclayHedge’s 2025 yearly performance rankings within the Fixed Income – Asset-Backed Loans category. BarclayHedge, a division of Backstop Solutions, publishes independent performance rankings across 39 hedge fund categories, with the asset-backed loans segment including funds focused on debt investments secured by underlying assets such as residential real estate. The New Silver Income Fund invests in residential transition loans and reports a 12% preferred return paid monthly, targeting total annual income between 12% and 14%, with quarterly…

Continue Reading

WednesdayFeb 18, 2026 11:01 am

QualityStocksNewsBreaks – LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Advances Beacon Gold Mill Restart in Val-d’Or Mining Camp 

This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising.  LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) provided an update on progress toward restarting its 100%-owned Beacon Gold Mill in Val-d’Or, Québec, alongside advancement of its Preliminary Economic Assessment and near-term production strategy. The Company reported that electrical upgrades and winterization improvements are largely complete, key mechanical systems have been refurbished and inspected, and modern safety enhancements have been installed, with approximately 30% of the restart budget deployed to date under cost control. Positioned within the prolific Abitibi Greenstone Belt and supported by its Swanson Gold Deposit located 60 kilometers from the mill,…

Continue Reading

WednesdayFeb 18, 2026 9:50 am

QualityStocksNewsBreaks – LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Appoints Sidney Braun as CEO of Liora Technologies Europe Subsidiary

LIXTE Biotechnology Holdings (NASDAQ: LIXT), a clinical-stage pharmaceutical and med-tech company advancing cancer treatments, announced the appointment of Sidney Braun as Chief Executive Officer of its Liora Technologies Europe Ltd. subsidiary. Braun, who previously facilitated LIXTE’s November 2025 acquisition of Liora’s assets, brings more than 20 years of healthcare operational and strategic advisory experience and will lead advancement of Liora’s LiGHT System, an electronically controlled proton therapy platform designed to enhance tumor treatment. Management said the appointment supports its strategy to scale the technology and pursue a recurring revenue model within the radiotherapy segment of cancer care. To view the…

Continue Reading

WednesdayFeb 18, 2026 9:40 am

QualityStocksNewsBreaks – Lahontan Gold Corp. (TSXV: LG) (OTCQB: LGCXF) Reports Additional Oxide Gold and Silver Intercepts at West Santa Fe

This article has been disseminated on behalf of Lahontan Gold Corp. and may include paid advertising. Lahontan Gold (TSXV: LG) (OTCQB: LGCXF) announced additional analytical results from its 2025 maiden drilling program at the West Santa Fe project in Nevada’s Walker Lane, including 48.8 meters grading 0.83 g/t Au Eq in hole WSF25-02R and 45.7 meters grading 0.64 g/t Au Eq in hole WSF25-05R, with mineralization beginning at surface and remaining open to the north and west. Management said the results confirm a 500-by-350-meter surface expression of gold and silver mineralization with thicknesses ranging from approximately 35 to nearly 60…

Continue Reading

WednesdayFeb 18, 2026 9:30 am

QualityStocksNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial on Late-Stage Biotech M&A Trends

Oncotelic Therapeutics (OTCQB: OTLC) announced its placement in an editorial published by BioMedWire, one of more than 75 brands within the Dynamic Brand Portfolio at IBN (InvestorBrandNetwork), highlighting the growing focus in biotech mergers and acquisitions on de-risked, late-stage assets with clinical validation. The article, titled “Why Late-Stage CNS, Oncology Assets Are Becoming the Hottest Targets in Biotech M&A,” examines how pharmaceutical companies and investors are prioritizing programs with established safety and efficacy data, placing companies such as Oncotelic, with multiple clinical- and late-stage oncology and central nervous system programs, in alignment with current M&A trends as it advances its…

Continue Reading

WednesdayFeb 18, 2026 9:20 am

QualityStocksNewsBreaks – Earth Science Tech, Inc. (OTC: ETST) Reports Fiscal Q3 2026 Revenue Up 14% and Net Income Up 341%

Earth Science Tech (OTC: ETST) reported financial and operational results for the third fiscal quarter ended Dec. 31, 2025, with revenue of $8.4 million, up 14.1% year over year, gross profit of $6.4 million reflecting a 76.3% margin, and net income of $910,000, up 341% from the prior-year period. Adjusted EBITDA totaled $1.2 million, total assets increased to $8.1 million, and the company repurchased and retired 3.7 million shares during the first nine months of fiscal 2026, while ending the quarter with $416,000 in cash, $773,000 in working capital and no bank debt as management cited continued operating leverage and…

Continue Reading

WednesdayFeb 18, 2026 9:10 am

QualityStocksNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Raises Preliminary FY 2025 Revenue to $38-$40 Million, Reaffirms $200 Million FY 2026 Target

Datavault AI (NASDAQ: DVLT) updated its preliminary, unaudited fiscal 2025 revenue estimate to $38 million to $40 million, exceeding its prior $30 million estimate by up to 33%, with midpoint growth of approximately 1,300% year over year, driven by customer tech-licensing fees and tokenization and monetization services from its Data Science Group. The company also reaffirmed its anticipated fiscal 2026 revenue target of $200 million, representing projected year-over-year growth of 400% to 426%, and said it plans to file its audited 2025 financial results with the SEC next month. To view the full press release, visit https://ibn.fm/Z5sSf About Datavault AI…

Continue Reading

TuesdayFeb 17, 2026 3:33 pm

QualityStocksNewsBreaks – Globavend Holdings Limited (NASDAQ: GVH) Reports 42.5% Revenue Growth for Fiscal 2025 

Globavend Holdings (NASDAQ: GVH) reported financial results for the year ended Sept. 30, 2025, with revenue rising 42.5% year over year to $23.6 million. The company said it handled an average of 10,394 packages per day, up 69.4% from the prior year, while average daily revenue per freight weight increased 12.7%. Net income totaled $0.68 million. During the year, Globavend established a subsidiary in China and built out corporate infrastructure to support expansion, as management cited capital markets support and a growing pipeline positioning the company for continued revenue growth into 2026 and beyond. To view the full press release, visit https://ibn.fm/MUSnQ About Globavend Holdings Limited Globavend Holdings Limited,…

Continue Reading

TuesdayFeb 17, 2026 2:41 pm

QualityStocksNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Completes FDA Type C Meeting for NRX-100 NDA Pathway 

NRx Pharmaceuticals (NASDAQ: NRXP) announced completion of an in-person Type C guidance meeting with the U.S. Food and Drug Administration, attended by leadership from the Division of Psychiatry Products, Office of Neuroscience and Center for Drug Evaluation and Research. Based on oral guidance, the company believes it has a path to file a New Drug Application for NRX-100, a preservative-free ketamine formulation, supported by existing adequate and well-controlled trials and confirmatory evidence from more than 65,000 patients in a Real World Evidence dataset, while also seeking a broader indication for treatment-resistant depression with suicidality. The FDA advised that no additional nonclinical or bridging studies would be required, and…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered